Savara, Inc. (SVRA)
5.02
-0.04
(-0.79%)
USD |
NASDAQ |
May 22, 16:00
5.12
+0.10
(+1.99%)
After-Hours: 20:00
Savara EPS Diluted (Quarterly) : -0.1472 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.8785 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.28M |
| Total Expenses (Quarterly) | 37.28M |
| Enterprise Value | 856.07M |
| Earnings Yield | -11.12% |
| Normalized Earnings Yield | -11.12 |